Eric Swayze sold $1.9M of Ionis Pharmaceuticals (IONS)

Executed Jan 2, disclosed Jan 6, 4 days later.

Value, as filed

$1.9M

23,463 sh across 2 lots

Executed

Jan 2

the trade date, as filed

Disclosed

Jan 6

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

ES Eric Swayze EVP Research profile →

Eric Swayze (EVP Research) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $1.9M of IONS (23,463 sh across 2 lots, as filed), executed Jan 2.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Swayze in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $839K
10,602 sh × $79.18
Exec Jun 25
Filed Jun 26 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.3M
15,642 sh across 2 lots
Exec Feb 13
Filed Feb 13 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $512K
6,179 sh × $82.93
Exec Jan 30
Filed Feb 2 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $745K
9,884 sh × $75.34
Exec Jan 16
Filed Jan 20 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $473K
6,849 sh × $69.02
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.8M
27,114 sh across 2 lots
Exec Oct 1 2025
Filed Oct 2 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $492K
10,000 sh × $49.22
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $235K
7,154 sh × $32.84
Exec Jan 16 2025
Filed Jan 17 2025 · 5:30 PM ET